Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Managing nusinersen therapy during pregnancy in spinal muscular atrophy type 3.
Journal: BMJ case reports
Published: July 15, 2026
Intermuscular coherence as a candidate biomarker for primary lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 13, 2026
Profiling circulating Tau and phospho-Tau isoforms in pediatric and adult spinal muscular atrophy identifies selective elevation of pTau-262 in adults.
Journal: Journal of neurology
Published: March 31, 2026
Circulating Tau Profiles in Pediatric and Adult Patients with Spinal Muscular Atrophy.
Journal: medRxiv : the preprint server for health sciences
Published: January 29, 2026
The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United States.
Journal: Neurology research international
Published: September 26, 2025
Research access barriers in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: July 31, 2025
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of Nusinersen in adult patients with spinal muscular atrophy.
Journal: Neuromuscular disorders : NMD
Published: June 18, 2025
A prospective, multi-center, observational study of the safety, tolerability and effectiveness of Nusinersen in adult patients with spinal muscular atrophy.
Journal: Neuromuscular disorders : NMD
Published: June 18, 2025
Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the US.
Journal: Muscle & nerve
Published: April 03, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Last Updated: 09/26/2026